Venture capital
Aglaia Oncology Funds
The Netherlands
- Stage
- Growth
- Focus
- Biotech and life sciences
- Check size
About this investor
Aglaia is a Dutch oncology specialist investor that selects and matures early-stage breakthrough inventions with the potential to transform cancer prevention, diagnosis and therapy.
Details come from public sources and the investor's own website, and may change. Always confirm an investor's current thesis before you reach out. Is this your firm? Update your listing.
Investor Match
Find the investors that fit your company.
Tell us your stage, sector and location. We rank 3,500+ investors and show your best matches on the globe, free, then email you the list.
